Economic evaluation of methadone maintenance treatment in HIV/AIDS control among injecting drug users in Dehong, China

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 24, Issue 6, 2012, Pages 756-762

  Xing, Yan ^a,b   Sun, Jiangping ^c   Cao, Weihua ^a   Lee, Liming ^a   Guo, Haoyan ^c   Li, Hui ^c   Duan, Song ^d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Dehong Prefecture Centre for Disease Control and Prevention   (China)

Author keywords

China; cost; cost effectiveness; HIV prevention; incidence; injecting drug users; methadone maintenance treatment

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHINA; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; DRUG COST; ECONOMIC EVALUATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAINTENANCE THERAPY; MORBIDITY; PRIORITY JOURNAL; VIRUS TRANSMISSION;

CHINA; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84861499460     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2011.630359     Document Type: Article

References (21)

1. Avants, S.K., Margolin, A., Usubiaga, M.H., and, Doebrick, C. 2004. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy. Journal of Substance Abuse Treatment, 26 (2): 67-78. (Pubitemid 38402015)
2. Beck, E.J., Harling, G., Gerbase, S., and, DeLay, P. 2010. The cost of treatment and care for people living with HIV infection: Implications of published studies, 1999-2008. Current Opinion in HIV and AIDS, 5 (3): 215-224.
3. Bergenstrom, A., McLeod, R., Sharma, M., Mesquita, F., Dorabjee, J., Atun, R., and, Rao, J.V. 2010. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia. International Journal of Drug Policy, 21 (2): 107-109.
4. Des Jarlais, D.C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D.C., and, Friedman, S.R. 2009. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99 (Suppl. 2): S445-451.
5. Des Jarlais, D.C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., and, Friedman, S.R. 1996. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348 (9033): 987-991. (Pubitemid 26340754)
6. Duan, S., Shen, S., Bulterys, M., Jia, Y., Yang, Y., Xiang, L., and, Jiang, Y. 2010. Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: A hard hit area along a major drug trafficking route. BMC Public Health, 10: 180
7. Duan, S., Xiang, L.F., Yang, Y.C., Ye, R.H., Jia, M.H., Luo, H.B., and, He, N. 2009. Incidence and risk factors on HIV infection among injection drug users in Dehong prefecture area of Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi, 30 (12): 1226-1229.
8. Gibson, D.R., Flynn, N.M., and, McCarthy, J.J. 1999. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 13 (14): 1807-1818. (Pubitemid 29509539)
9. Gonzalo, T., Garcia Goni, M., and, Munoz-Fernandez, M.A. 2009. Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART. AIDS Reviews, 11 (2): 79-90.
10. Jia, Y., Sun, J., Fan, L., Song, D., Tian, S., Yang, Y., and, Vermund, S.H. 2008. Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. International Journal of Epidemiology, 37 (6): 1287-1296.
11. Kumaranayake, L.P.J., Goodman, H., Mills, A., and, Walker, D. 2000. Costing guidelines for HIV/AIDS prevention strategies. UNAIDS best practice collection-key materials, Geneva: UNAIDS.
12. Marsch, L.A. 1998. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction, 93 (4): 515-532. (Pubitemid 28188071)
13. MOH. 2010. China 2010 UNGASS country progress report (2008-2009). China: Ministry of Health of the People's Republic of China.
14. Pang, L., Hao, Y., Mi, G., Wang, C., Luo, W., Rou, K., and, Wu, Z. 2007. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS, 21 (Suppl. 8): S103-107.
15. Renaud, A., Basenya, O., de Borman, N., Greindl, I., and, Meyer-Rath, G. 2009. The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi. AIDS Care, 21 (11): 1388-1394.
16. WHO/UNODC/UNAIDS. 2004. Position paper on Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Geneva: WHO,UNODC,UNAIDS.
17. Wodak, A., and, Maher, L. 2010. The effectiveness of harm reduction in preventing HIV among injecting drug users. New South Wales Public Health Bulletin, 21 (3-4): 69-73.
18. Wu, Z., Sullivan, S.G., Wang, Y., Rotheram-Borus, M.J., and, Detels, R. 2007. Evolution of China's response to HIV/AIDS. Lancet, 369 (9562): 679-690. (Pubitemid 46281314)
19. Zaric, G.S., Barnett, P.G., and, Brandeau, M.L. 2000. HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health, 90 (7): 1100-1111. (Pubitemid 30445365)
20. Xue-Ping, D., Feng, Z., Li, Z., Xin-Ping, Z., Hui, L., and, Yun-Zhen, C. 2008. Direct cost analysis of therapy on HIV-1 infection in rural area of China. Chinese Health Economics, 27 (10): 39-41.
21. Zhou, F., Kominski, G.F., Qian, H., Wang, J., Duan, S., Guo, Z., Zhao, X. 2011. Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs. BMC Medicine, 9 (1), 6. doi: http://dx.doi.org/10.1186/1741-7015-9-6. Retrieved from: http://www. escholarship.org/uc/item/7f0435d4